Home/Filings/4/0001209191-15-071929
4//SEC Filing

REVA Medical, Inc. 4

Accession 0001209191-15-071929

CIK 0001496268operating

Filed

Sep 21, 8:00 PM ET

Accepted

Sep 22, 8:44 PM ET

Size

8.6 KB

Accession

0001209191-15-071929

Insider Transaction Report

Form 4
Period: 2015-09-18
Brandom Donald K.
VP, Biomaterials Product Dev
Transactions
  • Sale

    Common Stock

    2015-09-18$4.28/sh200$85591,212.8 total
  • Sale

    Common Stock

    2015-09-21$4.37/sh3,662.8$16,01785,050 total
  • Sale

    Common Stock

    2015-09-21$4.45/sh2,500$11,11388,712.8 total
Footnotes (4)
  • [F1]The sale was executed in the form of CDIs, trading on the Austrialian Securities Exchange, and as such the sale price has been converted to a USD equivalent, adjusting for the ratio of 1 share of common stock per 10 CDIs, and the exchange rate on the date of the transaction.
  • [F2]Represents the sale of 2,000 of the Company's Chess Depositary Interests (CDIs), trading on the Austrialian Securities Exchange.
  • [F3]Represents the sale of 25,000 of the Company's Chess Depositary Interests (CDIs), trading on the Austrialian Securities Exchange.
  • [F4]Represents the sale of 36,628 of the Company's Chess Depositary Interests (CDIs), trading on the Austrialian Securities Exchange.

Issuer

REVA Medical, Inc.

CIK 0001496268

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001496268

Filing Metadata

Form type
4
Filed
Sep 21, 8:00 PM ET
Accepted
Sep 22, 8:44 PM ET
Size
8.6 KB